Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019-Reference-Cited by-同舟云学术

Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019

Published:2021-11 Issue: Volume:100 Page:108076
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Mohammadhosayni Mina,Sadat Mohammadi Fatemeh,Ezzatifar Fatemeh,Mahdavi Gorabi Armita,Khosrojerdi Arezou,Aslani Saeed,Hemmatzadeh Maryam,Yazdani Shahrooz,Arabi Mohsen,Marofi Faroogh,Jadidi-Niaragh Farhad,Shomali Navid,Mohammadi Hamed

Funder

Alborz University of Medical Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference34 articles.

1. N. Ebrahimi, S. Aslani, F. Babaie, M. Hemmatzadeh, R. Hosseinzadeh, Z. Joneidi, Z.M. Tourzani, N. Pakravan, H. Mohammadi, Recent findings on the Coronavirus disease 2019 (COVID-19)

2. immunopathogenesis and immunotherapeutics, International immunopharmacology (2020) 107082.

3. Multi-facets of neutrophil extracellular trap in infectious diseases: Moving beyond immunity;Tabrizi;Microb. Pathog.,2021

4. Extrapulmonary and atypical clinical presentations of COVID-19;Abobaker;J. Med. Virol.,2020

5. Neurologic features in severe SARS-CoV-2 infection;Helms;N. Engl. J. Med.,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Cerebral Creatine and N-Acetyl Aspartate Concentrations after Severe COVID-19 Infection: A Magnetic Resonance Spectroscopy Study;Journal of Clinical Medicine;2024-07-15

2. Serum Dehydroepiandrosterone sulfate (DHEA-S) level and its potential impact on immune responses and symptom severity after Oxford-AstraZeneca COVID-19 vaccination;International Immunopharmacology;2024-05

3. Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis;International Journal of Molecular Sciences;2024-04-18

4. Matrix metalloproteinases are associated with severity of disease among COVID‐19 patients: A possible pharmacological target;Basic & Clinical Pharmacology & Toxicology;2024-03-11

5. Correlation of iron and related factors with disease severity and outcomes and mortality of patients with Coronavirus disease 2019;Journal of Trace Elements in Medicine and Biology;2023-12